Stock Scorecard

Stock Summary for Petros Pharmaceuticals Inc (PTPI) - $0.26 as of 11/19/2024 10:50:06 AM EST

Total Score

11 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for PTPI

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for PTPI

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for PTPI

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for PTPI

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for PTPI (21 out of 90)

Stock Price Rating (Max of 10) 1
Historical Stock Price Rating (Max of 10) 1
Stock Price Trend (Max of 10) 0
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 10
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 3
Price to Earnings (Max of 10) 0

Latest News for for PTPI

EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros Pharma President Says - Petros Pharma ( NASDAQ:PTPI ) 6/17/2024 7:08:00 AM
Why Broadcom Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - Broadcom ( NASDAQ:AVGO ) 6/13/2024 12:16:00 PM
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Addex Therapeutics ( NASDAQ:ADXN ) , Agrify ( NASDAQ:AGFY ) 1/30/2024 12:52:00 PM
Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket - 180 Life Sciences ( NASDAQ:ATNF ) , Altisource Asset Mgmt ( AMEX:AAMC ) 12/13/2023 12:55:00 PM
Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech 11/15/2023 12:30:00 PM
Why Brooge Energy Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket - A10 Networks ( NYSE:ATEN ) , AgileThought ( NASDAQ:AGIL ) 10/4/2023 12:03:00 PM
's Stock Whisper Index: 5 Tickers Investors Secretly Monitor But Don't Talk About - Rivian Automotive ( NASDAQ:RIVN ) 7/14/2023 2:17:00 PM
Why Senmiao Technology Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Ault Alliance ( AMEX:AULT ) , Senmiao Tech ( NASDAQ:AIHS ) 7/13/2023 12:12:00 PM
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Aarons ( NYSE:AAN ) , Aclarion ( NASDAQ:ACON ) 4/25/2023 5:33:00 PM
Nasdaq Down 50 Points; US Home Price Index Rises In February - CXApp ( NASDAQ:CXAI ) , Aarons ( NYSE:AAN ) 4/25/2023 1:56:00 PM

Financial Details for PTPI

Company Overview
Ticker PTPI
Company Name Petros Pharmaceuticals Inc
Country USA
Description Petros Pharmaceuticals, Inc. is dedicated to identifying, acquiring, developing and marketing therapies for men's health problems in the United States and internationally. The company is headquartered in New York, New York.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 9/30/2024
Next Earnings Date N/A

Stock Price History
Last Day Price 0.26
Price 4 Years Ago 0.00
Last Day Price Updated 11/19/2024 10:50:06 AM EST
Last Day Volume 52,285
Average Daily Volume 280,396
52-Week High 2.27
52-Week Low 0.22
Last Price to 52 Week Low 18.18%

Valuation Measures
Trailing PE N/A
Industry PE 22.60
Sector PE 40.32
5-Year Average PE -9.45
Free Cash Flow Ratio 0.67
Industry Free Cash Flow Ratio 12.03
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 0.85
Total Cash Per Share 0.39
Book Value Per Share Most Recent Quarter 4.04
Price to Book Ratio 0.32
Industry Price to Book Ratio 5.31
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 0.63
Industry Price to Sales Ratio Twelve Trailing Months 11.82
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 0
Analyst Strong Buy Ratings 1

Share Statistics
Total Shares Outstanding 10,008,800
Market Capitalization 2,602,288
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 59.26%
Reported EPS 12 Trailing Months -6.33
Reported EPS Past Year -2.59
Reported EPS Prior Year -6.34
Net Income Twelve Trailing Months -4,727,200
Net Income Past Year -8,163,188
Net Income Prior Year -20,037,573
Quarterly Revenue Growth YOY -28.70%
5-Year Revenue Growth -7.11%
Operating Margin Twelve Trailing Months -1.61

Balance Sheet
Total Cash Most Recent Quarter 3,900,000
Total Cash Past Year 13,300,000
Total Cash Prior Year 9,426,264
Net Cash Position Most Recent Quarter -3,348,635
Net Cash Position Past Year 5,286,086
Long Term Debt Past Year 8,013,914
Long Term Debt Prior Year 9,477,776
Total Debt Most Recent Quarter 7,248,635
Equity to Debt Ratio Past Year 0.60
Equity to Debt Ratio Most Recent Quarter 0.30
Total Stockholder Equity Past Year 12,071,041
Total Stockholder Equity Prior Year 16,702,467
Total Stockholder Equity Most Recent Quarter 3,115,711

Free Cash Flow
Free Cash Flow Twelve Trailing Months -5,828,354
Free Cash Flow Per Share Twelve Trailing Months -0.58
Free Cash Flow Past Year -7,626,530
Free Cash Flow Prior Year 0

Options
Put/Call Ratio 0.00
Has Options False
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -0.02
MACD Signal -0.01
20-Day Bollinger Lower Band 0.26
20-Day Bollinger Middle Band 0.35
20-Day Bollinger Upper Band 0.45
Beta 2.28
RSI 34.49
50-Day SMA 4.21
150-Day SMA 0.00
200-Day SMA 10.48

System
Modified 11/19/2024 10:50:08 AM EST